Highly Cited Researchers 2023
Since 2014, Clarivate Analytics has published an annual list of researchers who have demonstrated significant and broad influence in their field(s) of research over the past decade. These Highly Cited Researchers have published scientific publications which rank in the top 1% by citations for their field(s) and publication year in the Web of Science™ index. In 2023, Université Paris-Saclay is along the top 50 higher education institutions with the highest number of Highly Cited Researchers in the world, with a total of 26 researchers.
In 2023, Clarivate has distinguished the following researchers from Université Paris-Saclay:
Laurence Albiges is a medical oncologist, professor at Université Paris-Saclay, and head of the Medical Oncology Department at Gustave Roussy. She is a member of the team specialised in the impact of tumour microenvironment on tumour resistance within the unit for Integrative Tumour Immunology and Immunotherapy (INTIM – Univ. Paris-Saclay, Institut Gustave-Roussy, Inserm, EPHE).
Fabrice André is an oncologist within the Breast Pathology Committee at Gustave Roussy, and head of the Molecular Predictors and New Targets in Oncology unit (PMNCO – Univ. Paris-Saclay, Institut Gustave Roussy, Inserm). He is also head of the team specialised in the molecular characterisation of breast and gynaecologic cancers.
Fabrice Barlesi is a professor of medicine at Université Paris-Saclay and Director General of Gustave Roussy. He is specialised in lung cancer, precision medicine and cancer immunology.
Benjamin Besse is a professor of medical oncology at Université Paris-Saclay and a clinical research director at Gustave Roussy. He specialises in thoracic cancers and is a member of the team specialised in genetic tumour adaptation to kinase inhibitors within the Molecular Predictors and New Targets in Oncology unit (PMNCO – Univ. Paris-Saclay, Institut Gustave Roussy, Inserm).
Claire Chenu is a professor in soil science at AgroParisTech, and also head of research at the Functional Ecology and Ecotoxicology of Agroecosystems Laboratory (Ecosys – Univ. Paris-Saclay, AgroParisTech, INRAE).
Philippe Ciais is a research director at the Laboratory for Sciences of Climate and Environment (LSCE – Univ. Paris-Saclay, UVSQ, CEA, CNRS). He oversaw the development of a greenhouse gas monitoring network, which has become a key part of Integrated Carbon Observation System (ICOS), and for which he coordinated the preparatory phase in Europe.
Franck Courchamp is an ecologist and CNRS research director at the Ecology, Systematics and Evolution Laboratory (ESE – Univ. Paris-Saclay, CNRS, AgroParisTech). As a specialist in animal population dynamics and conservation biology, he studies the impact of climate change on biodiversity.
Patrick Couvreur is an Emeritus Professor at the Institut Galien Paris-Saclay (IGPS – Univ. Paris-Saclay, CNRS) and a pioneer in nanomedicine, an approach which allows therapeutic molecules to target directly the tissues and cells of patients with serious diseases (cancer, nervous-system diseases).
Vincent Cros is a researcher at the CNRS/Thales Joint Physics Research Unit (UMPHY – Univ. Paris-Saclay, CNRS, Thales) and explores magnetisation dynamics and spin torque phenomena, and their potential applications. Since 2023, he has been co-director of the CNRS Priority Research Programme and Equipment (PEPR), SPIN, which aims to promote a new cycle of innovation in spintronics.
Joël Doré is a researcher in intestinal microbial ecology at the Micalis Institute (MICALIS – Univ. Paris-Saclay, INRAE, AgroParisTech) and the scientific director of the MetaGenoPolis research unit for Excellence in Microbiome Analysis (MGP – Univ. Paris-Saclay, INRAE). He is one the world’s leading experts in human microbiota.
Charles-Antoine Dutertre is a researcher at the Tumour Immunology and Anti-Cancer Immunotherapy unit (ITIC - Univ. Paris-Saclay, Inserm, Gustave Roussy).
Stanislav Dusko Ehrlich contributed to the creation of the MetaGenoPolis centre (MGP – Univ. Paris-Saclay, INRAE) in 2012, and was the former scientific and technical head of the project.
Albert Fert was awarded the Nobel Prize for Physics in 2007 for the discovery of giant magnetoresistance (GMR). He is an Emeritus Professor at Université Paris-Saclay and a researcher at the CNRS/Thales Joint Physics Research Unit (UMPHY – Univ. Paris-Saclay, CNRS, Thales), which he co-founded.
Karim Fizazi is a medical oncologist specialised in prostate cancer and a professor of oncology at Université Paris-Saclay. He was head of the medical oncology department at Institut Gustave Roussy and is currently head of the institute’s Genitourinary Committee. He is also a member of the team specialised in adaptative resistance to anticancer-therapies within the Molecular Predictors and New Targets in Oncology unit (PMNCO – Univ. Paris-Saclay, Institut Gustave Roussy, Inserm).
Florent Ginhoux is a member of the Tumour Immunology and Anti-Cancer Immunotherapy unit (ITIC - Univ. Paris-Saclay, Inserm, Gustave Roussy). He is a specialist in macrophage ontogeny and differentiation.
Marc Humbert is a professor of pneumology at Université Paris-Saclay and head of the Pulmonology and Respiratory Intensive Care Department at Bicêtre Hospital, where he is also head of the Reference Centre for Pulmonary Hypertension Reference. He manages the Pulmonary Hypertension: Physiopathology and Therapeutic Innovation Laboratory (HPPIT – Univ. Paris-Saclay, Inserm). Since 2023, he has been dean of the Faculty of Medicine at Université Paris-Saclay.
Aurélien Marabelle is a medical oncologist and professor at Université Paris-Saclay. He is head of the Translational Research in Immunotherapy Laboratory (LRTI) within the Tumour Immunology and Anti-Cancer Immunotherapy unit (ITIC - Univ. Paris-Saclay, Inserm, Gustave Roussy).
Xavier Mariette is a specialist in rheumatology and a professor of rheumatology at Université Paris-Saclay. Since 2015, he has led the team specialised in autoimmunity at the Infectious Disease Models and Innovative Therapies Laboratory (IMVA-HB – Univ. Paris-Saclay, Inserm, CEA).
Graham Noctor is a researcher in plant biology. He is head of the Climate Change and Redox Signalling team at the Institute of Plant Sciences - Paris-Saclay (IPS2 – Univ. Paris-Saclay, Univ. d’Évry, INRAE, CNRS, Univ. Paris Cité).
David Planchard is a thoracic oncologist and professor at Université Paris-Saclay. He is head of the thoracic pathology committee at Gustave Roussy, where he leads the coordination of treating patients with lung cancer, pleural mesothelioma or thymic tumours. He is a member of the team specialised in genetic tumour adaptation to kinase inhibitors within the Molecular Predictors and New Targets in Oncology unit (PMNCO – Univ. Paris-Saclay, Institut Gustave Roussy, Inserm). He is also chair of the International Thoracic Cancer Centre (CICT).
Marco Di Renzo is a research director at the Laboratory of Signals and Systems (L2S – Univ. Paris-Saclay, CentraleSupélec, CNRS) where he is head of the team specialised in intelligent physical communications. He is a pioneer in metamaterials and wireless networks, for which he has created numerous models and algorithms.
Caroline Robert is a professor at Université Paris-Saclay and head of dermatology at Gustave Roussy. She also oversees teaching in dermatology at the university’s Faculty of Medicine. She is also head of the team specialised in adaptative resistance to anticancer-therapies within the Molecular Predictors and New Targets in Oncology unit (PMNCO – Univ. Paris-Saclay, Institut Gustave Roussy, Inserm).
Gérald Simonneau is an Emeritus Professor at Université Paris-Saclay and pulmonologist at the Pulmonary Hypertension: Physiopathology and Therapeutic Innovation Laboratory (HPPIT – Univ. Paris-Saclay, Inserm). He is a specialist in Pulmonary Arterial Hypertension, and has contributed to the discovery of key medicine which has transformed the prognosis of the rare disease.
Jean-Charles Soria is a medical oncologist and professor of medicine and medical oncology at Université Paris-Saclay. He was Director General at Gustave Roussy, Europe’s leading cancer centre, from January 2020 to July 2021.
Gaël Varoquaux is a researcher in computer science and head of the team behind the Soda project at the Paris-Saclay Inria centre. He is a leading expert in the field of artificial intelligence and is particularly renowned for his work in statistical learning.
Laurence Zitvogel is a medical oncologist at Gustave Roussy and a professor of immunology at Université Paris-Saclay. She is head of the Tumour Immunology and Anti-Cancer Immunotherapy unit (ITIC - Univ. Paris-Saclay, Inserm, Gustave Roussy).